Buttonhole Versus Step Ladder Cannulation in High Dose Hemodialysis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01962025 |
|
Recruitment Status :
Completed
First Posted : October 14, 2013
Results First Posted : September 29, 2020
Last Update Posted : September 29, 2020
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Renal Failure | Procedure: Buttonhole needling technique | Not Applicable |
To determine the feasibility of 1) randomizing patients to step-ladder versus buttonhole cannulation techniques, and 2) coordinating the multiple Canadian sites that are required for the definitive study.
Secondary Objectives: To determine 1) if buttonhole cannulation, compared to step-ladder cannulation is associated with reduced training time for high dose home hemodialysis patients, 2) if buttonhole cannulation, compared to step-ladder cannulation is associated with reduced overall cost, 3) if buttonhole cannulation, compared to step-ladder cannulation is associated with reduced complications (infection - local and systemic, radiologic/surgical interventions, re-trains for needle insertion difficulties, hematoma formation, aneurysm formation, missed insertions), and 4) if buttonhole cannulation, compared to step-ladder cannulation is associated with reduced patient discomfort with needling for intensive home hemodialysis patients
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 14 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Other |
| Official Title: | Vanguard Multi-Centre Feasibility Trial to Determine if Buttonhole Versus Step Ladder Cannulation for High Dose Hemodialysis is Associated With Reduced Overall Cost |
| Study Start Date : | October 2013 |
| Actual Primary Completion Date : | November 2017 |
| Actual Study Completion Date : | February 11, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Buttonhole needling technique
the intervention is the Buttonhole needling technique for home hemodialysis
|
Procedure: Buttonhole needling technique
the intervention is the type of needling used for home hemodialysis patients. They will be randomized to either buttonhole cannulation or stepladder cannulation
Other Name: Buttonhole canulation in home hemodialysis patients |
|
No Intervention: Step Ladder Group
Patients will use step ladder needling technique
|
- Feasibility of Participant Recruitment and Site Coordination [ Time Frame: 2 years ]The percent of qualified patients enrolled in the study for the pilot study to be successful will be ≥70%. If we can not reach this target we will not move forward with the definitive study. The pilot study will also allow us to see if we can coordinate multiple sites in needling techniques and determine if we can move forward with the definitive study.
- Participant Training Time [ Time Frame: Up to 90 days ]Time in Days that it takes to train participants to perform home hemodialysis (document time in days from start of training until discharge home to do self-care). Unit of measure is number of days required to independently perform home hemodialysis
- Cost [ Time Frame: 12 Months ]Will incorporate the cost of training and complications
- Number of Participants With Complications [ Time Frame: 12 Months ]To determine whether buttonhole cannulation, compared to step-ladder cannulation, is associated with reduced complications (infection - local and systemic, radiologic/surgical interventions, re-trains for needle insertion difficulties, hematoma formation, aneurysm formation, missed insertions).
- Pain With Needling [ Time Frame: baseline, end of training (2 months), and 2 months after graduating training (4 months) ]Pain/discomfort during cannulation will be measured using a 10cm (0 mm to 100 mm) visual analogue scale, which ranges from "No Pain" (0 mm) on the left side to "Extreme Pain" (100 mm) on the right. The participant is instructed to place a mark on the scale according to the amount of pain felt during needling the fistula that day. The visual analogue scale with be completed at baseline, end of training, and 2 months after graduating training. The mean of these three assessments will be calculated.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 90 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult patients > 18 years old,
- Training for home hemodialysis
- Able to give informed consent,
- Arteriovenous fistula 5. Life expectancy of greater than 12 months.
Exclusion Criteria:
- Potential to be lost from the program within 12 months of training (planned living donor transplant, transfer to peritoneal dialysis (PD) or move from training centre catchment area),
- Allergy to mupirocin,
- Short segments or aneurysms within the arteriovenous fistula (AVF) that the attending nephrologist believes require buttonhole cannulation.,
- Mechanical heart valves,
- Patients who require intradermal lidocaine for needle insertion -
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01962025
| Canada, Alberta | |
| Foothills Hospital | |
| Calgary, Alberta, Canada | |
| Canada, Ontario | |
| London Health Sciences Centre | |
| London, Ontario, Canada | |
| Ottawa Hospital | |
| Ottawa, Ontario, Canada, K1H 7W9 | |
| Principal Investigator: | Deborah Zimmerman, MD, MSc | Ottawa Hospital Research Institute |
Documents provided by Ottawa Hospital Research Institute:
| Responsible Party: | Ottawa Hospital Research Institute |
| ClinicalTrials.gov Identifier: | NCT01962025 |
| Other Study ID Numbers: |
20130148 |
| First Posted: | October 14, 2013 Key Record Dates |
| Results First Posted: | September 29, 2020 |
| Last Update Posted: | September 29, 2020 |
| Last Verified: | September 2020 |
|
Renal failure Hemodialysis Canulation technique |
Training time Cost Patient discomfort with cannulation technique |
|
Renal Insufficiency Kidney Diseases Urologic Diseases |

